Anna Von Landenberg
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas.
Journal: Nature cancer
Published: July 15, 2020
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Journal: Nature communications
Published: November 25, 2019
Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology.
Journal: Nature communications
Published: March 29, 2019
Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer.
Journal: Journal of translational medicine
Published: February 21, 2018
Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
Journal: EBioMedicine
Published: February 18, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.
Journal: Nature medicine
Published: February 16, 2018
Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.
Journal: Frontiers in immunology
Published: October 25, 2017
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis.
Journal: EBioMedicine
Published: February 27, 2017
Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.
Journal: Oncotarget
Published: February 25, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026